Consolidated Portfolio Review Corp Insulet Corp Transaction History
Consolidated Portfolio Review Corp
- $429 Billion
- Q2 2024
A detailed history of Consolidated Portfolio Review Corp transactions in Insulet Corp stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 3,755 shares of PODD stock, worth $811,493. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,755
Previous 3,760
0.13%
Holding current value
$811,493
Previous $644 Million
17.58%
% of portfolio
0.18%
Previous 0.17%
Shares
6 transactions
Others Institutions Holding PODD
# of Institutions
659Shares Held
63.5MCall Options Held
385KPut Options Held
773K-
Vanguard Group Inc Valley Forge, PA8.4MShares$1.82 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$1.55 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.31 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.86MShares$618 Million0.03% of portfolio
-
Baillie Gifford & CO1.89MShares$408 Million0.3% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $15B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...